Key result
Genetically predicted obstructive sleep apnea was associated with an increased risk of high blood pressure (OR 1.010; 95% CI 1.002-1.018) and type 2 diabetes mellitus (OR 1.140; 95% CI 1.059-1.228).
Why the study?
Obstructive sleep apnea, high blood pressure, and type 2 diabetes mellitus have a close clinical relationship, but the causal effects and mechanisms of OSA on HBP and T2DM are unclear.
Does genetic predisposition to obstructive sleep apnea increase the risk of high blood pressure and type 2 diabetes mellitus?
Observational
Does genetic predisposition to obstructive sleep apnea increase the risk of high blood pressure and type 2 diabetes mellitus?
Odds Ratio: 1.01 (95% CI 1.002–1.018)
p-value: p=0.0121
Genetic predisposition to obstructive sleep apnea is associated with an increased risk of high blood pressure and type 2 diabetes, with sex hormones and lipid profiles acting as partial mediators.
Supports OSA screening in cardiometabolic risk assessment; leaves open whether treating OSA alters hypertension or diabetes incidence.
Background: Obstructive sleep apnea (OSA), high blood pressure (HBP), and type 2 diabetes mellitus (T2DM) have a close clinical relationship, but whether and how OSA affects HBP and T2DM is unclear. Study Design and Methods: Two-step, two-sample Mendelian randomization techniques were applied using single-nucleotide polymorphisms as genetic instruments for exposure and mediators, thus minimizing bias due to confounding factors and reverse causality. The total effect of OSA on HBP and T2DM was categorized into direct and mediating effects based on the mediating factors. Results: Two-sample MR analysis showed that OSA increased the risk of HBP (odds ratio [OR] = 1.010, 95% confidence interval [CI], 1.002– 1.018; P = 0.0121) and T2DM (OR = 1.140, 95% CI, 1.059– 1.228; P = 0.0005). In the process of OSA caused by HBP, sex hormone-binding globulin (SHBG) (female, 4.47% mediation; male, 2.76% mediation), total testosterone (TT) (male, 3.72% mediation), bioavailable testosterone (BioT) (female, 7.74% mediation), high-density lipoprotein cholesterol (HDL-C) (3.25% mediation), and apolipoprotein A1 (ApoA1) (1.31% mediation) were individual contributors. SHBG (female, 4.10% mediation; male, 1.58% mediation), TT (male, 3.69% mediation), BioT (female, 2.58% mediation), HDL-C (3.32% mediation), ApoA1 (2.14% mediation), and omega-6 fatty acids (2.33% mediation) may have mediating roles to varying degrees in the process of OSA caused by T2DM. Interpretation: This MR study showed that OSA is a risk factor for HBP and T2DM, and the evaluation of mediators may help further reveal the specific mechanism by which OSA causes HBP and T2DM.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2023) conducted an observational in Obstructive sleep apnea, high blood pressure, type 2 diabetes mellitus. Obstructive sleep apnea was evaluated on High blood pressure (OR 1.010, 95% CI 1.002-1.018, p=0.0121). Genetically predicted obstructive sleep apnea was associated with an increased risk of high blood pressure (OR 1.010; 95% CI 1.002-1.018) and type 2 diabetes mellitus (OR 1.140; 95% CI 1.059-1.228).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: